In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease

The in vitro susceptibility of three strains of an unclassified Mycobacterium sp., isolated from three patients with Crohn's disease, to 23 antimicrobial agents was determined by a modified broth dilution method with 7H9 broth containing oleic acid-albumin-dextrose-catalase, Tween 80, and mycobactin J. All three strains were susceptible to streptomycin, viomycin, rifampin, clofazimine, cefazolin, amikacin, and kanamycin and resistant to p-aminosalicylic acid, cycloserine, 2-thiophenecarboxylic acid hydrazide, trimethoprim, diaminodiphenylsulfone, sulfamethoxazole, sulfadimethoxine, polymyxin B, metronidazole, neomycin, and carbenicillin. Variable results between strains were encountered with ethambutol, ethionamide, capreomycin, amoxicillin, and cephalothin.

[1]  R. Chiodini,et al.  Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease , 1984, Journal of clinical microbiology.

[2]  U. Klotz,et al.  Treatment of Crohn's disease with peroral 5-aminosalicylic acid. , 1983, Gastroenterology.

[3]  M. Cynamon,et al.  In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis , 1983, Antimicrobial Agents and Chemotherapy.

[4]  Y. Mizuguchi,et al.  Mechanism of Antibiotic Resistance in Mycobacterium intracellulare , 1983, Microbiology and immunology.

[5]  R. Wallace,,et al.  Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei , 1982, Journal of clinical microbiology.

[6]  J. Aronson,et al.  The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. , 1982, British journal of clinical pharmacology.

[7]  Nalin Rastogi,et al.  Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? , 1981, Antimicrobial Agents and Chemotherapy.

[8]  G. T. ten Velde,et al.  Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. , 1981, Gut.

[9]  M. Cynamon,et al.  In vitro susceptibility of Mycobacterium fortuitum to cefoxitin , 1981, Antimicrobial Agents and Chemotherapy.

[10]  G. Järnerot,et al.  Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. , 1981, Scandinavian journal of gastroenterology.